Published in JAMA on July 21, 2004
Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy (2009) 1.87
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ (2014) 1.67
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol (2011) 1.56
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
Asthma exacerbations . 4: Prevention. Thorax (2006) 1.17
Adenosine receptors and asthma in humans. Br J Pharmacol (2008) 0.93
The effects of nebulized albuterol on esophageal function in asthmatic patients. Dig Dis Sci (2008) 0.90
Similarities and differences between asthma health care professional and patient views regarding medication adherence. Can Respir J (2014) 0.82
Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response. Respir Res (2012) 0.82
A simulation model approach to analysis of the business case for eliminating health care disparities. BMC Med Res Methodol (2011) 0.81
New approaches to managing asthma: a US perspective. Ther Clin Risk Manag (2008) 0.81
Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation. Eur J Pharmacol (2006) 0.81
Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. BMC Pulm Med (2013) 0.81
Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort study. NPJ Prim Care Respir Med (2014) 0.80
Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study. Allergy Asthma Clin Immunol (2014) 0.77
Risk of adverse gastrointestinal events from inhaled corticosteroids. Pharmacotherapy (2008) 0.77
How effective are common medications: a perspective based on meta-analyses of major drugs. BMC Med (2015) 0.76
Impact of patients' judgment skills on asthma self-management: a pilot study. J Public Health Res (2014) 0.75
Ciclesonide in persistent asthma: the evidence of its therapeutic value. Core Evid (2006) 0.75
Review: long term use of common medications for asthma reduces exacerbations in adults. Evid Based Nurs (2005) 0.75
Section 3. A discussion of flexible dosing and patient-centered therapy: highlights of the asthma summit 2009: beyond the guidelines. World Allergy Organ J (2010) 0.75
Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol. Ther Clin Risk Manag (2010) 0.75
Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children. Patient Prefer Adherence (2016) 0.75
Increased rhinovirus replication in nasal mucosa cells in allergic subjects is associated with increased ICAM-1 levels and endosomal acidification and is inhibited by L-carbocisteine. Immun Inflamm Dis (2016) 0.75
Effective Strategies for Managing Asthma Exacerbations for Precision Medicine. Allergy Asthma Immunol Res (2017) 0.75
Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics. Inflammation (2015) 0.75
Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA (2003) 4.88
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation (2003) 4.63
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest (2005) 4.41
Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 3.88
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.85
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.93
Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82
Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.41
Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med (2002) 2.36
Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc (2005) 2.17
Inhaled corticosteroids for chronic obstructive pulmonary disease. BMJ (2012) 2.04
The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med (2007) 2.04
The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest (2005) 1.91
The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med (2002) 1.90
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol (2009) 1.68
Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med (2002) 1.67
Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia. Am J Med (2005) 1.64
The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest (2012) 1.50
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients? Curr Opin Pulm Med (2007) 1.41
Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol (2008) 1.38
The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med (2003) 1.36
The airway epithelium: more than just a structural barrier. Ther Adv Respir Dis (2011) 1.30
Can universal access to health care eliminate health inequities between children of poor and nonpoor families?: A case study of childhood asthma in Alberta. Chest (2003) 1.23
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23
Court reporters: a viable solution for the challenges of focus group data collection? Qual Health Res (2009) 1.19
Asthma and COPD among aboriginals in Alberta, Canada. Chest (2002) 1.17
The role of female hormones on lung function in chronic lung diseases. BMC Womens Health (2011) 1.16
The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One (2012) 1.12
Management of asthma among community-based primary care physicians. J Asthma (2005) 1.12
Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer. Am J Respir Crit Care Med (2005) 1.09
Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol (2005) 1.08
Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol (2007) 1.05
Divergence of mechanisms regulating respiratory burst in blood and sputum eosinophils and neutrophils from atopic subjects. J Immunol (2003) 1.05
Effects of increased primary care access on process of care and health outcomes among patients with asthma who frequent emergency departments. Am J Med (2004) 1.01
The relationship between birth weight and childhood asthma: a population-based cohort study. Arch Pediatr Adolesc Med (2004) 1.01
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med (2005) 1.01
Interleukin-6: a red herring or a real catch in COPD? Chest (2008) 1.00
Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc (2009) 0.95
Surfactant protein D: a lung specific biomarker in COPD? Ther Adv Respir Dis (2008) 0.93
Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res (2008) 0.93
Epidemic of lung cancer in patients with HIV infection. Chest (2013) 0.92
The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection. AIDS Patient Care STDS (2014) 0.90
Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. Curr Opin Pulm Med (2008) 0.90
Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD. Chest (2007) 0.90
Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immun (2009) 0.88
Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J (2011) 0.87
Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Eur J Pharmacol (2006) 0.86
Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs (2006) 0.85
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. BMC Pulm Med (2006) 0.85
The costs of implementing the 1999 Canadian Asthma Consensus Guidelines recommendation of asthma education and spirometry for the family physician. Can Respir J (2004) 0.83
Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.83
The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis. BMC Pulm Med (2012) 0.83
Thinning bone and inhaled corticosteroid in COPD: what to do until there is definitive proof? Chest (2009) 0.82
Biomarkers in COPD: are we there yet? Chest (2008) 0.82
Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer. Chest (2008) 0.82
The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD). PLoS One (2013) 0.81
Systemic consequences of COPD. Ther Adv Respir Dis (2007) 0.81
A curious case of beta-blockers in chronic obstructive pulmonary disease. Arch Intern Med (2010) 0.80
The role of the basolateral outwardly rectifying chloride channel in human airway epithelial anion secretion. Am J Respir Cell Mol Biol (2003) 0.79
Primary Care Pathway for Childhood Asthma: Protocol for a Randomized Cluster-Controlled Trial. JMIR Res Protoc (2016) 0.79
Is systemic inflammation responsible for pulmonary hypertension in COPD? Chest (2006) 0.78
NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. Magn Reson Med (2004) 0.78
The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women. BMC Pulm Med (2006) 0.77
Asthma control and management in the community: indices in 1997 compared with indices in 2002. Can Fam Physician (2006) 0.77
Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease. Curr Pharm Des (2004) 0.76
CT in COPD: just a pretty picture or really worth a thousand words (or dollars)? Thorax (2011) 0.76
Commentary: fuelling the fire--systemic inflammation and development of lung disease in the general community. Int J Epidemiol (2006) 0.76
The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease. Ther Adv Respir Dis (2009) 0.76
Serum Bilirubin and Disease Progression in Mild COPD. Chest (2015) 0.75
Reply to letter from Mirrakhimov and Mirrakhimov. Can J Cardiol (2013) 0.75
Reply: beneficial effects of angiotensin receptor blockade in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 0.75
Recruitment for a provincial asthma study. Participation of network and non-network primary care physicians. Can Fam Physician (2004) 0.75
Inhaled glucocorticoids in COPD: immortal time bias. Am J Respir Crit Care Med (2003) 0.75
Could oral hypoglycemics be the new therapeutic answer to chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2010) 0.75
Sleep-disordered breathing and heart disease: is it one big, vicious loop? Circulation (2011) 0.75
Gamma Knife patients' experience: lessons learned from a qualitative study. J Neurooncol (2009) 0.75
Spirometric findings among school-aged First Nations children on a reserve: a pilot study. Can Respir J (2004) 0.75
Effects of clarithromycin on inflammatory cell mediator release and survival. Chemotherapy (2005) 0.75
Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease. Drugs Aging (2003) 0.75